<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Oral Maxillofac Pathol</journal-id>
<journal-id journal-id-type="iso-abbrev">J Oral Maxillofac Pathol</journal-id>
<journal-id journal-id-type="publisher-id">JOMFP</journal-id>
<journal-title-group>
<journal-title>Journal of Oral and Maxillofacial Pathology : JOMFP</journal-title>
</journal-title-group>
<issn pub-type="ppub">0973-029X</issn>
<issn pub-type="epub">1998-393X</issn>
<publisher>
<publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
<publisher-loc>India</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27194874</article-id>
<article-id pub-id-type="pmc">4860913</article-id>
<article-id pub-id-type="publisher-id">JOMFP-20-122</article-id>
<article-id pub-id-type="doi">10.4103/0973-029X.180967</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetics: A possible answer to the undeciphered etiopathogenesis and behavior of oral lesions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Narendra Nath</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peer</surname>
<given-names>Aakanksha</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nair</surname>
<given-names>Sherin</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chaturvedi</surname>
<given-names>Rupesh K</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
</contrib-group>
<aff id="aff1">
<italic>Department of Oral Pathology and Microbiology, Kothiwal Dental College and Research Center, Moradabad, Uttar Pradesh, India</italic>
</aff>
<author-notes>
<corresp id="cor1">
<bold>Address for correspondence:</bold>
<italic> Dr. Aakanksha Peer, Department of Oral Pathology and Microbiology, Kothiwal Dental College and Research Center, Moradabad - 244 001, Uttar Pradesh, India. E-mail: <email xlink:href="aakanksha.peer@gmail.com">aakanksha.peer@gmail.com</email></italic>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Jan-Apr</season>
<year>2016</year>
</pub-date>
<volume>20</volume>
<issue>1</issue>
<fpage>122</fpage>
<lpage>128</lpage>
<history>
<date date-type="received">
<day>06</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2016 Journal of Oral and Maxillofacial Pathology</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
</license>
</permissions>
<abstract>
<p>Much controversy has existed over the etiopathogenesis and management of oral lesions, especially oral malignancies. The knowledge of genetic basis is proving to be inadequate in the light of emerging new mechanisms termed epigenetic phenomena. The present review article aims to understand the role of epigenetic mechanisms in oral lesions. Epigenetics is the study of acquired changes in chromatin structure that arise independently of a change in the underlying deoxyribonucleic acid (DNA) nucleotide sequence. Key components involved in epigenetic regulation are DNA methylation, histone modifications and modifications in micro ribonucleic acids (miRNA). Epigenetics is a reversible system that can be affected by various environmental factors such as diet, drugs, mental stress, physical activity and addictive substances such as tobacco, nicotine and alcohol. Epigenetics may also play a role in explaining the etiopathogenesis of developmental anomalies, genetic defects, cancer as well as substance addiction (tobacco, cigarette and alcohol). Epigenetic modifications may contribute to aberrant epigenetic mechanisms seen in oral precancers and cancers. In the near future, epigenetic variations found in oral dysplastic cells can act as a molecular fingerprint for malignancies. The literature in English language was searched and a structured scientific review and meta-analysis of scientific publications from the year 2000 to year 2015 was carried out from various journals. It was observed that epigenetic marks can prove to be novel markers for early diagnosis, prognosis and treatment of oral cancers as well as other oral diseases.</p>
</abstract>
<kwd-group>
<kwd>Deoxyribonucleic acid (DNA) methylation</kwd>
<kwd>Epigenome</kwd>
<kwd>histone modification</kwd>
<kwd>micro-ribonucleic acid (miRNAs)</kwd>
<kwd>oral cancer</kwd>
<kwd>small interfering ribonucleic acids (siRNAs)</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Despite enormous research in the fields of diagnosis and management of oral premalignancies and malignancies; their etiopathogenesis and behavior have long been a matter of discussion, debate and controversy and not many advancements have been possible in managing these lesions. Oral malignancies are still graded based on the tumor/node/metastasis staging and despite extensive research, no functional classification based on histopathological typing or molecular profiling is presently being used at cancer management centers and hospitals. Another matter of debate has been the fact that an increasing number of cases of oral premalignancies and malignancies are not related to any deleterious habits, which questions their etiopathogenesis that is commonly related to habits such as chewing of tobacco and its products, areca nut usage, cigarette smoking and alcohol consumption. Over the years, the treatment approach for oral malignancies has remained constant. Excision and removal of the tumor usually remain the only choices for management and most specialists still feel handicapped at actually treating the tumor or preventing its recurrence. Another aspect of the etiopathogenesis of orofacial neoplasms has been their genetic basis. Much of the research at the genetic level has been carried out on chromosomal mutations and other genetic defects, but even this has not helped in achieving pinpoint diagnosis or prompt treatment in most cases of oral malignancies. This has led to speculations about the role of phenomena other than genetic events, which have been termed “Epigenetics.” In the past few years, many researchers have made attempts to decipher these internal mechanisms and have postulated the rectification of these mechanisms, when they appear aberrant, for possible management of the oral diseases and malignancies. This has been authenticated by evidence showing inter-generational exchange of genetic information by the genome, by mechanisms other than its basic genetic material.</p>
<p>Epigenetic changes have been described as stable but potentially reversible alterations in a cell's genetic information that result in changes in gene expression but do not involve changes in the underlying deoxyribonucleic acid (DNA) sequence.[<xref ref-type="bibr" rid="ref1">1</xref><xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref3">3</xref>] Some changes that may occur in the lifetime of the parent may in turn affect the phenotype of their offspring, leading to an epigenetic phenomenon that is transgenerational.[<xref ref-type="bibr" rid="ref4">4</xref>] The concept of epigenes (transposable elements in our genes) as factors travelling with the genes between generations is becoming increasingly popular. Various factors have been identified in the environment, diet and habits of an individual which affect not only the person but also subsequent generations.[<xref ref-type="bibr" rid="ref5">5</xref>] Epigenetic modifications cause remodelling of the chromatin which results in activation or inactivation of a gene, thus contributing to the development of diseases including malignancies.[<xref ref-type="bibr" rid="ref6">6</xref>] Three key mechanisms involved in epigenetic regulation have been identified, namely DNA modifications, histone modifications and ribonucleic acid (RNA) modifications. Although epigenetics and genetics are individual and distinct fields, potential interactions have been observed to occur between them. Epigenetic marks may influence genetic changes such as mutation, transposition and recombination of DNA sequence and the predisposition of a gene to be selected for epigenetic changes. Furthermore, the mechanisms enabling epigenetic effects are themselves subject to evolution.[<xref ref-type="bibr" rid="ref4">4</xref>] Hence, the present review was done to understand the evolution and concepts of epigenetics and to understand its significance in relation to oral lesions, especially oral cancer.</p>
<p>To understand the role of epigenetic mechanisms in oral lesions, especially oral malignancies, the literature in English language was searched and a structured scientific review and meta-analysis of scientific publications from the year 2000 to 2015 was carried out from various journals using search engines such as PubMed, Wiley, Google Scholar, Science Direct and EBSCO host. The keywords Oral cancer, Epigenetics, DNA methylation, Histone modification, miRNA, small interfering RNAs (siRNA), tobacco, cigarette, alcohol, oral rinses and buccal swabs were used for the search.</p>
<p>For a long time, environmental and genetic factors were thought to be independent mechanisms, but recent evidence suggests that epigenetics bridges these two factors.[<xref ref-type="bibr" rid="ref7">7</xref>] The term epigenetics was coined by Waddington in the 20<sup>th</sup> century and he hypothesized that patterns of gene expression define each cell type, turning genes on and off, thus linking genes to development.[<xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref11">11</xref>] <xref ref-type="table" rid="T1">Table 1</xref>[<xref ref-type="bibr" rid="ref12">12</xref><xref ref-type="bibr" rid="ref13">13</xref><xref ref-type="bibr" rid="ref14">14</xref><xref ref-type="bibr" rid="ref15">15</xref><xref ref-type="bibr" rid="ref16">16</xref>] provides a brief description of the historical perspective of epigenetics. Genetic and epigenetic mechanisms are very closely related. Yet, there are many important differences between the two systems. Unlike genetic changes, epigenetic changes do not depend on DNA sequence changes but depend on modifications of the DNA, other than those involving the basic sequence of adenine, guanine, cytosine and thymine nucleotides.[<xref ref-type="bibr" rid="ref3">3</xref>] Genetic changes are stable and can rarely be reversed, whereas epigenetic changes are often reversible.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref10">10</xref>] The genotype is constant except for changes caused by mutagens and there is no inheritance of acquired characteristics, whereas the epigenetic process is dynamic and changes in response to diseases and environmental factors.[<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref10">10</xref>] In contrast to genetic changes which usually involve a single gene, epigenetic modifications involve more than one gene.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref17">17</xref><xref ref-type="bibr" rid="ref18">18</xref><xref ref-type="bibr" rid="ref19">19</xref>] Epigenetic mechanisms that modify chromatin structure can be divided into three main categories: DNA modifications, histone modifications and modifications of noncoding RNAs (ncRNAs). These modifications work together to regulate the functioning of the genome by regulating the dynamics of chromatin.[<xref ref-type="bibr" rid="ref9">9</xref>] <xref ref-type="fig" rid="F1">Flowchart 1</xref> helps to understand the mechanism by which epigenetic phenomena function.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Historical events in epigenetics</p>
</caption>
<graphic xlink:href="JOMFP-20-122-g001"></graphic>
</table-wrap>
<fig id="F1" position="float">
<label>Flowchart 1</label>
<caption>
<p>Epigenetic phenomena</p>
</caption>
<graphic xlink:href="JOMFP-20-122-g002"></graphic>
</fig>
<p>The first evidence that DNA methylation or demethylation might have an important biological role was provided by Griffith and Mahler in 1969.[<xref ref-type="bibr" rid="ref10">10</xref>] Currently, DNA methylation is the most studied epigenetic mechanism.[<xref ref-type="bibr" rid="ref20">20</xref>] Studies have shown that DNA methylation provides a stable gene silencing mechanism that plays an important role in regulating gene expression and chromatin architecture.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref21">21</xref>] The DNA can be modified by the addition of methyl groups to specific DNA sequences with cytosine and guanine bases separated by a phosphate molecule (CpG islands).[<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref20">20</xref>] X-chromosome inactivation (XCI) and imprinted genes are classic examples of naturally occurring CpG island methylation during development.[<xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref22">22</xref>] This process of DNA methylation is regulated by DNA methyltransferases (DNMTs). Presently, five DNMTs have been identified: Dnmt1, Dnmt2, Dnmt3a, Dnmt3b and DnmtL.[<xref ref-type="bibr" rid="ref15">15</xref><xref ref-type="bibr" rid="ref23">23</xref><xref ref-type="bibr" rid="ref24">24</xref>] There is strong evidence that DNA methylation can provide a primary switch for epigenetics.[<xref ref-type="bibr" rid="ref10">10</xref>] Loss of DNA methylation is related to increased risk of tumors due to chromosomal instability. It has been considered as the earliest epigenetic change from a normal cell to a premalignant cell.[<xref ref-type="bibr" rid="ref8">8</xref>]</p>
<p>The DNA is wrapped around a histone core to form the nucleosome, which forms the fundamental unit of the chromatin. These histone proteins are themselves subject to reversible epigenetic modifications by processes such as methylation, acetylation, phosphorylation, biotinylation, ubiquitination, sumoylation and adenosine diphosphate ribosylation which occur at the N-terminal tails of histones and regulate important cellular processes such as transcription, replication and repair.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref21">21</xref><xref ref-type="bibr" rid="ref25">25</xref>] The most studied histone modifications are methylation, acetylation and phosphorylation. These modifications are mediated by enzymes such as histone methyltransferases, histone demethylases, histone acetyltransferases, histone deacetylases, histone phosphorylases and histone phosphatases.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref24">24</xref><xref ref-type="bibr" rid="ref25">25</xref><xref ref-type="bibr" rid="ref26">26</xref>] The combined effect of all these modifications has been termed “histone crosstalk.”[<xref ref-type="bibr" rid="ref23">23</xref>] Histone modifications can lead to either activation of the genes (associated with a loosely packed chromatin) or inactivation of the genes (associated with a compact chromatin). These histone modifications are proposed to play a key role in determining cellular identity.[<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref9">9</xref>] Of late, various potential roles of histone proteins have been postulated which include uses such as prognostic biomarkers in the detection of aggressive behavior of tumors as well as a predictive factor of chemotherapy and radiotherapy response.[<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref22">22</xref>]</p>
<p>Along with changes in the DNA and supporting histone framework, certain RNA modifications have also been proposed to cause epigenetic changes. These mainly occur in the ncRNAs that are classified according to their size as a first group of small ncRNAs, which include siRNAs and P-element induced wimpy testis-interacting RNAs and a second group of micro RNAs (miRNAs).[<xref ref-type="bibr" rid="ref27">27</xref>] miRNAs play an essential role in modifying gene expression as well as in controlling DNA methylation and histone modifications. They can function as both oncogenes and tumor suppressors genes and can regulate target genes with important functions in carcinogenesis such as TPM1, PTEN and bcl-2.[<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref15">15</xref><xref ref-type="bibr" rid="ref28">28</xref>] miRNA profiles can also be used to classify human cancers.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref16">16</xref>] Recently, much work has been carried out on the role of miR-21, miR-345 and miR-181b in oral cancer progression.[<xref ref-type="bibr" rid="ref28">28</xref>] siRNAs are a class of short, double-stranded RNAs which are involved in the RNA interference (RNAi) pathway and suppress the expression of specific genes. They have been shown to be involved in both DNA methylation and histone modifications.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref19">19</xref>] All these mechanisms of DNA, histone and RNA modifications are closely interrelated and are responsible for regulating gene expression in the healthy cells as well as may instigate aberrant gene expressions in cancer cells. Much lesser investigated epigenetic mechanisms include small regulatory RNA molecules, non-covalent mechanisms (such as nucleosome remodeling and replacement of canonical histone proteins with specialized histone variants), self-sustaining loops and structural inheritance.[<xref ref-type="bibr" rid="ref4">4</xref><xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref10">10</xref>]</p>
<p>Various factors can provoke epigenetic changes. These may be physiological or pathological. Epigenetic changes increase during life and age itself may be a risk factor for epigenetic changes. Studies have proved that the mother's diet influences fetal development as well as affects the offspring as an adult. Several nutritional factors such as folate, Vitamin B12, Vitamin A, methionine, choline, betaine, biotin, niacin, pantothenic acid and zinc as well as bioactive dietary components (genistein and polyphenols) may result in epigenetic modifications, which in turn participate in events such as embryonic development, aging and carcinogenesis.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref21">21</xref>] The epigenome may be especially plastic during early development of the individual and is susceptible to modifications. Thus, intervention at this stage can provide a therapeutic advantage.[<xref ref-type="bibr" rid="ref22">22</xref>]</p>
<p>Significant effects of various habits have been found in relation to epigenetic changes.[<xref ref-type="bibr" rid="ref25">25</xref><xref ref-type="bibr" rid="ref26">26</xref>] Long-term epigenetic changes in the DNA have been found in smokers.[<xref ref-type="bibr" rid="ref11">11</xref>] In actively drinking individuals, increased levels of homocysteine have been found, which plays an important role in DNA methylation.[<xref ref-type="bibr" rid="ref15">15</xref><xref ref-type="bibr" rid="ref17">17</xref>] In squamous cell carcinoma of the head and neck, alcohol has been also found to be associated with changes in the methylation pattern.[<xref ref-type="bibr" rid="ref6">6</xref>]</p>
<p>Epigenetics can play a role in health as well as disease. Role of various bacteria and viruses has been implicated in epigenetic mechanisms. Bacteria-induced epigenetic deregulations may affect host cell function either to promote host defense or to allow pathogen persistence.[<xref ref-type="bibr" rid="ref29">29</xref>] Pathogens in the oral mucosa may cause epigenetic changes in the host, which may, in turn, influence the progression of disease or cancer. In patients with squamous cell carcinoma of the head and neck region, bacteria were shown to be associated with methylation of the multidrug resistance gene and increase in methylation in the E-cadherin gene after <italic>Helicobacter pylori</italic> stimulation was also observed.[<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref6">6</xref>] Virus-induced epigenetic changes include changes due to chronic human immunodeficiency virus (HIV) infection that has revealed epigenetic changes in key genes. Studies have recently found an association between poorly differentiated head and neck squamous cell carcinoma and human papillomavirus-16. The bacterial pathogens that cause periodontal diseases are known to cause epigenetic modifications to the genomes of Epstein–Barr virus, Kaposi sarcoma-associated herpes virus and HIV, which may be of significance for understanding the etiopathogenesis of virus-associated malignancies.[<xref ref-type="bibr" rid="ref30">30</xref><xref ref-type="bibr" rid="ref31">31</xref>]</p>
<p>Development of oral cancer is a multistep process involving an accumulation of genetic and epigenetic alterations resulting in cellular dysregulation and uncontrolled growth.[<xref ref-type="bibr" rid="ref32">32</xref>] Markert has stated that normal gene activity is misprogrammed by epigenetic mechanisms to produce a neoplastic pattern of metabolism in which all of the individual components are normal.[<xref ref-type="bibr" rid="ref3">3</xref>] Cellular aging and chronic inflammation may be potential inducers of epigenetic alterations in oral mucosal cells.[<xref ref-type="bibr" rid="ref5">5</xref>] Epimutations can lead to silencing of tumor suppressor genes independently and also in conjunction with deleterious genetic mutations or deletions; thus, serving as the second hit in the “two-hit” model of carcinogenesis proposed by Knudson. Hypermethylation and consequent silencing of several tumor suppressor genes have been identified in oral cancers. The genes found hypermethylated include cell cycle control genes (p16, p15), apoptosis genes (p14, DAPK, p73 and RASSF1A), Wnt signaling genes (APC, WIF1, RUNX3), cell-cell adhesion genes (E-cadherin), DNA-repair genes (MGMT, BRCA1 and hMLH1), tumor suppressor genes (p16, MLH1, BRCA1 <italic>CDKN2A</italic>, <italic>pRB</italic>, <italic>APC</italic>, <italic>PTEN</italic>, <italic>BRCA1</italic>, <italic>VHL</italic> and <italic>CDH1</italic>), metastasis-related genes, hormone receptor genes and genes inhibiting angiogenesis.[<xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref33">33</xref><xref ref-type="bibr" rid="ref34">34</xref><xref ref-type="bibr" rid="ref35">35</xref><xref ref-type="bibr" rid="ref36">36</xref>] The tumor microenvironment may itself be viewed as an epigenetic modifier with the potential to promote or prevent malignant outgrowth.[<xref ref-type="bibr" rid="ref36">36</xref>] Multiple factors and mechanisms have been discovered which have a potential role in carcinogenesis. These include loss of imprinting; E-cadherin hypermethylation; reduced expression of the enzyme death associated protein kinase; hypermethylation of genes p14, p15, p16; DNA methylation in the promoter region is deleted in colorectal cancer (DCC) gane; hypermethylation of MINT 1 and MINT 31 and epigenetic deregulation of Notch signaling.[<xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref15">15</xref><xref ref-type="bibr" rid="ref35">35</xref><xref ref-type="bibr" rid="ref36">36</xref><xref ref-type="bibr" rid="ref37">37</xref>] Methylated genes in tumors identified in recent investigations in head and neck squamous cell carcinoma such as HOXA9, HS3ST2, NPY, EYA4 and WT1 have been suggested as biomarkers for early detection of oral cancers.[<xref ref-type="bibr" rid="ref37">37</xref>] Studies have reported using methylation-specific polymerase chain reaction in oral rinses and found that hypermethylation status of circulating DNA could be used as a tumor marker to monitor patients with premalignant and malignant oral lesions. Other studies have identified up to seven novel DNA methylation markers in oral rinse samples from oral cancer patients.[<xref ref-type="bibr" rid="ref32">32</xref>] Epigenetic modifications are tissue specific and DNA from oral rinses, buccal swabs or whole saliva could be used for determining the epigenetic status of oral tissues.[<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref38">38</xref>] miRNA levels have also been found to be differentially expressed in oral squamous cell carcinoma tissues, serum and saliva. These can provide biomarkers for early diagnosis of oral squamous cell carcinoma. They can also serve as a potential biomarkers of nutritional status in humans.[<xref ref-type="bibr" rid="ref1">1</xref><xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref33">33</xref>] Diseases caused by the expression of a dominant gene can be treated by ligand-targeted nanoparticles for siRNA.[<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref21">21</xref>] Various studies have demonstrated the possibility to detect hypermethylation in saliva. Biomarkers based on the methylation profile evaluation in exfoliated mucosa cell samples could represent a powerful class of minimally invasive markers for squamous cell carcinoma detection.[<xref ref-type="bibr" rid="ref1">1</xref><xref ref-type="bibr" rid="ref25">25</xref><xref ref-type="bibr" rid="ref26">26</xref><xref ref-type="bibr" rid="ref33">33</xref><xref ref-type="bibr" rid="ref39">39</xref>]</p>
<p>Epigenetics has provided a new dimension to clinical genetics. Epigenetic dysregulation in diseases is increasingly being studied as a potential mediator of pathophysiology of various diseases and malignancies.[<xref ref-type="bibr" rid="ref40">40</xref><xref ref-type="bibr" rid="ref41">41</xref><xref ref-type="bibr" rid="ref42">42</xref>] In recent years, epigenetics has become an emerging mechanism in the etiology of diseases such as Type 2 diabetes mellitus, obesity, inflammation, neurocognitive disorders, cardiovascular diseases, neurodegenerative diseases and immune diseases.[<xref ref-type="bibr" rid="ref18">18</xref><xref ref-type="bibr" rid="ref21">21</xref><xref ref-type="bibr" rid="ref43">43</xref><xref ref-type="bibr" rid="ref44">44</xref>] X-inactivation and imprinting are the other major types of epigenetic events that occur in cancer. Several diseases and syndromes occur with abnormal DNA methylation or imprinted gene sites including Silver–Russell syndrome, Beckwith–Wiedemann syndrome, Angelman syndrome, Prader–Willi syndrome, Williams syndrome, Di George-Velocardiofacial syndrome, Fragile X syndrome, autism, schizophrenia, Rett's syndrome and XCI disorders such as Ring Turner syndrome.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref39">39</xref><xref ref-type="bibr" rid="ref41">41</xref><xref ref-type="bibr" rid="ref45">45</xref>] Epigenetic alterations are currently used clinically as diagnostic markers of various diseases.[<xref ref-type="bibr" rid="ref29">29</xref><xref ref-type="bibr" rid="ref41">41</xref><xref ref-type="bibr" rid="ref46">46</xref>] <xref ref-type="table" rid="T2">Table 2</xref> gives a brief description of how epigenetics affects oral health and its role in causing oral lesions.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Orofacial pathologies linked to epigenetics</p>
</caption>
<graphic xlink:href="JOMFP-20-122-g003"></graphic>
</table-wrap>
<p>Factors in the diet such as retinoids have been shown to suppress carcinogenesis in a variety of epithelial tissues including skin and oral mucosa.[<xref ref-type="bibr" rid="ref5">5</xref>] Certain natural compounds such as sulforaphane found in cruciferous vegetables, compounds from garlic and grapes, genistein and curcumin have been found to alter epigenetic patterns.[<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref21">21</xref>] Epigenetic changes can be exploited for therapeutic intervention, which is authenticated by the recent Food and Drug Administration on approval of three epigenetic drugs for cancer treatment.[<xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref23">23</xref><xref ref-type="bibr" rid="ref34">34</xref><xref ref-type="bibr" rid="ref36">36</xref><xref ref-type="bibr" rid="ref39">39</xref><xref ref-type="bibr" rid="ref47">47</xref><xref ref-type="bibr" rid="ref48">48</xref>]</p>
<p>The concept of inherited epigenetic susceptibility to tobacco-related cancers can be used for identification of susceptible individuals to allow more focused prevention strategies in oral cancers. The cell cycle regulator p15 predicts malignant transformation and has been targeted.[<xref ref-type="bibr" rid="ref35">35</xref>] Various tests have been generated and devised to understand epigenetic information. These include a single gene-based DNA methylation assay, a microarray-based epigenomic assay and a high-density bead chip-based epigenomic assay.[<xref ref-type="bibr" rid="ref22">22</xref><xref ref-type="bibr" rid="ref41">41</xref>] Recent sequencing technology has revealed the presence of copy-number variations, which are associated with susceptibility to common diseases.[<xref ref-type="bibr" rid="ref41">41</xref>] Currently, several epigenetic drugs are being tested in clinical trials or are already being used.[<xref ref-type="bibr" rid="ref18">18</xref><xref ref-type="bibr" rid="ref22">22</xref><xref ref-type="bibr" rid="ref36">36</xref>] Development of several small molecule inhibitors such as SGI-1027, RG-108 and MG-98 has provided nonnucleoside compounds, which can effectively inhibit DNA methylation without being incorporated into the DNA.[<xref ref-type="bibr" rid="ref49">49</xref>] Several pathways appear to be specifically epigenetically deregulated in the cases showing greatest biological aggression that often prove refractory to aggressive conventional therapies, emphasizing the need for epigenetic biomarker panels.[<xref ref-type="bibr" rid="ref33">33</xref>]</p>
<p>The rapidly evolving field of epigenetics is contributing to our understanding of gene-environment interactions. The future appears bright if the knowledge of epigenetic phenomena can be utilized for deriving diagnostic, therapeutic and prognostic information about oral malignancies and also other oral diseases.[<xref ref-type="bibr" rid="ref35">35</xref><xref ref-type="bibr" rid="ref50">50</xref>] Hypermethylation of oncogene promoters in oral mucosal cells can serve as a molecular fingerprint which can be very helpful in diagnosis as well as classification of malignancies. Revealing hypermethylation present in histologically negative margins in carcinoma cases could be a useful molecular marker for predicting the overall survival of the patient.[<xref ref-type="bibr" rid="ref5">5</xref>] Spreading awareness about epigenetic mechanisms and their role in health could encourage a more balanced lifestyle, discouraging any deleterious habits in individuals.[<xref ref-type="bibr" rid="ref42">42</xref><xref ref-type="bibr" rid="ref51">51</xref><xref ref-type="bibr" rid="ref52">52</xref>]</p>
<p>Presently, many studies are being undertaken to understand epigenetic mechanisms better in both health and disease. Studies from northern Sweden show an association between the childhood food supply of the father or the paternal grandparents and the offspring's longevity or risk of diabetic or cardiovascular mortality. A contemporary United Kingdom cohort study also shows an association between paternal onset of smoking in mid-childhood and increased body mass index in their future sons. Similarly, a contemporary population from Taiwan shows an association between paternal betel nut chewing and early onset of the metabolic syndrome in the offspring. The sequencing of the human genome is being followed by the epigenome project, which will eventually unravel the significance of the field of epigenetics.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref22">22</xref>]</p>
</sec>
<sec id="sec1-2" sec-type="conclusion">
<title>CONCLUSION</title>
<p>Presently, much research is going on in the field of epigenetics. Epigenetic marks can provide new insights in the early diagnosis, prognosis and treatment of oral precancers, cancers and various other oral diseases. DNA from oral rinses and buccal swabs can serve as a routinely used noninvasive tool that can be employed for screening for epigenetic alterations in oral tissues. In addition, epigenetics can be utilized for the development of novel therapeutic interventions for various developmental diseases as well as for addiction. Thus, epigenetic therapy is now a reality that can change our future for good. The change in our genes has been impossible, but the change in our epigenes now appears possible!</p>
<sec id="sec2-1">
<title>Financial support and sponsorship</title>
<p>Nil.</p>
</sec>
<sec id="sec2-2">
<title>Conflicts of interest</title>
<p>There are no conflicts of interest</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lod</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Abrahamsson</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The influence of epigenetics in relation to oral health</article-title>
<source/>Int J Dent Hyg
          <year>2014</year>
<volume>12</volume>
<fpage>48</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">23730835</pub-id>
</element-citation>
</ref>
<ref id="ref2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doolittle</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Webster-Cyriaque</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Polymicrobial infection and bacterium-mediated epigenetic modification of DNA tumor viruses contribute to pathogenesis</article-title>
<source/>MBio
          <year>2014</year>
<volume>5</volume>
<fpage>e01015</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">24781742</pub-id>
</element-citation>
</ref>
<ref id="ref3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chadwick</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Baccarelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Breakefield</surname>
<given-names>XO</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>HW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>New insights and updated guidelines for epigenome-wide association studies</article-title>
<source/>Neuroepigenetics
          <year>2014</year>
<volume>4</volume>
<fpage>32</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="ref4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langevin</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Eliot</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pawlita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maccani</surname>
<given-names>JZ</given-names>
</name>
<name>
<surname>McClean</surname>
<given-names>MD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Novel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinoma</article-title>
<source/>Oral Oncol
          <year>2014</year>
<volume>50</volume>
<fpage>1072</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">25242135</pub-id>
</element-citation>
</ref>
<ref id="ref5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brito</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Guimarães</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia</article-title>
<source/>J Oral Pathol Med
          <year>2014</year>
<volume>43</volume>
<fpage>211</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">24020903</pub-id>
</element-citation>
</ref>
<ref id="ref6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arantes</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>de Carvalho</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Melendez</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Goloni-Bertollo</surname>
<given-names>EM</given-names>
</name>
</person-group>
<article-title>Methylation as a biomarker for head and neck cancer</article-title>
<source/>Oral Oncol
          <year>2014</year>
<volume>50</volume>
<fpage>587</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">24656975</pub-id>
</element-citation>
</ref>
<ref id="ref7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>González-Ramírez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Soto-Reyes</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sánchez-Pérez</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Herrera</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>García-Cuellar</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Histones and long non-coding RNAs: The new insights of epigenetic deregulation involved in oral cancer</article-title>
<source/>Oral Oncol
          <year>2014</year>
<volume>50</volume>
<fpage>691</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">24844984</pub-id>
</element-citation>
</ref>
<ref id="ref8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>McCormick</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Eapen</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Yohannes</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chance</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjects</article-title>
<source/>Epigenetics
          <year>2013</year>
<volume>8</volume>
<fpage>703</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">23804146</pub-id>
</element-citation>
</ref>
<ref id="ref9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jithesh</surname>
<given-names>PV</given-names>
</name>
<name>
<surname>Risk</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Schache</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Dhanda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liloglou</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The epigenetic landscape of oral squamous cell carcinoma</article-title>
<source/>Br J Cancer
          <year>2013</year>
<volume>108</volume>
<fpage>370</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">23287992</pub-id>
</element-citation>
</ref>
<ref id="ref10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieratschker</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Batra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fallgatter</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Genetics and epigenetics of alcohol dependence</article-title>
<source/>J Mol Psychiatry
          <year>2013</year>
<volume>1</volume>
<fpage>11</fpage>
<pub-id pub-id-type="pmid">25408904</pub-id>
</element-citation>
</ref>
<ref id="ref11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schardt</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Epigenetics: It's what turns you on and off</article-title>
<source/>Nut Act Health Lett
          <year>2013</year>
<volume>4</volume>
<fpage>9</fpage>
<lpage>11</lpage>
</element-citation>
</ref>
<ref id="ref12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Perceptions of epigenetics</article-title>
<source/>Nature
          <year>2007</year>
<volume>447</volume>
<fpage>396</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">17522671</pub-id>
</element-citation>
</ref>
<ref id="ref13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holliday</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Epigenetics: A historical overview</article-title>
<source/>Epigenetics
          <year>2006</year>
<volume>1</volume>
<fpage>76</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">17998809</pub-id>
</element-citation>
</ref>
<ref id="ref14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jablonka</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>The changing concept of epigenetics</article-title>
<source/>Ann N Y Acad Sci
          <year>2002</year>
<volume>981</volume>
<fpage>82</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">12547675</pub-id>
</element-citation>
</ref>
<ref id="ref15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haig</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The (dual) origin of epigenetics</article-title>
<source/>Cold Spring Harb Symp Quant Biol
          <year>2004</year>
<volume>19</volume>
<fpage>1</fpage>
<lpage>4</lpage>
</element-citation>
</ref>
<ref id="ref16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Speybroeck</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>From epigenesis to epigenetics: The case of C. H. Waddington</article-title>
<source/>Ann N Y Acad Sci
          <year>2002</year>
<volume>981</volume>
<fpage>61</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">12547674</pub-id>
</element-citation>
</ref>
<ref id="ref17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The epigenetics of oral cancer</article-title>
<source/>Int J Oral Maxillofac Surg
          <year>2006</year>
<volume>35</volume>
<fpage>101</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">16154320</pub-id>
</element-citation>
</ref>
<ref id="ref18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Pui</surname>
<given-names>NN</given-names>
</name>
</person-group>
<article-title>Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: Prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis</article-title>
<source/>Carcinogenesis
          <year>2009</year>
<volume>30</volume>
<fpage>1387</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">19351790</pub-id>
</element-citation>
</ref>
<ref id="ref19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seffer</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Nemeth</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Matics</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Seffer</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Koller</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Unexplored potentials of epigenetic mechanisms of plants and animals-theoretical considerations</article-title>
<source/>Genet Epigenet
          <year>2013</year>
<volume>5</volume>
<fpage>23</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">25512705</pub-id>
</element-citation>
</ref>
<ref id="ref20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mascolo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Siano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ilardi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Merolla</surname>
<given-names>F</given-names>
</name>
<name>
<surname>De Rosa</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenetic disregulation in oral cancer</article-title>
<source/>Int J Mol Sci
          <year>2012</year>
<volume>13</volume>
<fpage>2331</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">22408457</pub-id>
</element-citation>
</ref>
<ref id="ref21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selvi</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Senapati</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>TK</given-names>
</name>
</person-group>
<article-title>Small molecule modulators of epigenetic modifications: Implications in therapeutics</article-title>
<source/>Curr Sci
          <year>2012</year>
<volume>102</volume>
<fpage>29</fpage>
<lpage>36</lpage>
</element-citation>
</ref>
<ref id="ref22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bierne</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hamon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cossart</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Epigenetics and bacterial infections</article-title>
<source/>Cold Spring Harb Perspect Med
          <year>2012</year>
<volume>2</volume>
<fpage>a010272</fpage>
<pub-id pub-id-type="pmid">23209181</pub-id>
</element-citation>
</ref>
<ref id="ref23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kubota</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hirasawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Epigenetic understanding of gene-environment interactions in psychiatric disorders: A new concept of clinical genetics</article-title>
<source/>Clin Epigenetics
          <year>2012</year>
<volume>4</volume>
<fpage>1</fpage>
<pub-id pub-id-type="pmid">22414323</pub-id>
</element-citation>
</ref>
<ref id="ref24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dawson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kouzarides</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Cancer epigenetics: From mechanism to therapy</article-title>
<source/>Cell
          <year>2012</year>
<volume>150</volume>
<fpage>12</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">22770212</pub-id>
</element-citation>
</ref>
<ref id="ref25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rigi-Ladiz</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kordi-Tamandani</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Torkamanzehi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Analysis of hypermethylation and expression profiles of APC and ATM genes in patients with oral squamous cell carcinoma</article-title>
<source/>Clin Epigenetics
          <year>2011</year>
<volume>3</volume>
<fpage>6</fpage>
<pub-id pub-id-type="pmid">22414247</pub-id>
</element-citation>
</ref>
<ref id="ref26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals</article-title>
<source/>Nat Genet
          <year>2003</year>
<volume>33</volume>
<issue>Suppl</issue>
<fpage>245</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">12610534</pub-id>
</element-citation>
</ref>
<ref id="ref27">
<label>27</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Santoro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pannone</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Papagerakis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Serpico</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Guida</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lo Muzio</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Kalu U. E.</surname>
<given-names>Ogbureke</given-names>
</name>
</person-group>
<article-title>Epigenetic profiling in oral cancer</article-title>
<source/>Oral Cancer
          <year>2012</year>
<date-in-citation>Last assessed on 2016 Mar 21</date-in-citation>
<edition>1st ed</edition>
<publisher-loc>Shangai (china)</publisher-loc>
<publisher-name>Intechopen</publisher-name>
<fpage>297</fpage>
<lpage>325</lpage>
<comment>Available from: <uri xlink:href="http://www.intechopen.com/books/oral-cancer/epigenetic-profiling-of-oral-cancer" xlink:type="simple">http://www.intechopen.com/books/oral-cancer/epigenetic-profiling-of-oral-cancer</uri></comment>
</element-citation>
</ref>
<ref id="ref28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobor</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Focus on: Epigenetics and fetal alcohol spectrum disorders</article-title>
<source/>Alcohol Res Health
          <year>2011</year>
<volume>34</volume>
<fpage>29</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="pmid">23580038</pub-id>
</element-citation>
</ref>
<ref id="ref29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lester</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Tronick</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nestler</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Abel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kosofsky</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kuzawa</surname>
<given-names>CW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Behavioral epigenetics</article-title>
<source/>Ann N Y Acad Sci
          <year>2011</year>
<volume>1226</volume>
<fpage>14</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="pmid">21615751</pub-id>
</element-citation>
</ref>
<ref id="ref30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathews</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Janusek</surname>
<given-names>LW</given-names>
</name>
</person-group>
<article-title>Epigenetics and psychoneuroimmunology: Mechanisms and models</article-title>
<source/>Brain Behav Immun
          <year>2011</year>
<volume>25</volume>
<fpage>25</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">20832468</pub-id>
</element-citation>
</ref>
<ref id="ref31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKay</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Mathers</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Diet induced epigenetic changes and their implications for health</article-title>
<source/>Acta Physiol (Oxf)
          <year>2011</year>
<volume>202</volume>
<fpage>103</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">21401888</pub-id>
</element-citation>
</ref>
<ref id="ref32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kryza</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Perspectives of psychosomatic medicine: An integration of psychoneuroimmunology and epigenetics</article-title>
<source/>Perspect Psychosom Med
          <year>2011</year>
<volume>5</volume>
<fpage>45</fpage>
<lpage>62</lpage>
</element-citation>
</ref>
<ref id="ref33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Drugs and addiction: An introduction to epigenetics</article-title>
<source/>Addiction
          <year>2011</year>
<volume>106</volume>
<fpage>480</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">21205049</pub-id>
</element-citation>
</ref>
<ref id="ref34">
<label>34</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Tollefsbol</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Epigenetics in Human Disease</article-title>
<year>2012</year>
<edition>1st ed</edition>
<publisher-loc>UK</publisher-loc>
<publisher-name>Elsevier</publisher-name>
</element-citation>
</ref>
<ref id="ref35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfeifer</surname>
<given-names>GP</given-names>
</name>
</person-group>
<article-title>Hydroxymethylated cytosine in development and disease?</article-title>
<source/>Epigenetics Chromatin
          <year>2013</year>
<volume>6</volume>
<issue>suppl 1</issue>
<fpage>8</fpage>
<comment>DOI: 10.1186/1756-8935-6-S1-O8</comment>
<pub-id pub-id-type="pmid">23607454</pub-id>
</element-citation>
</ref>
<ref id="ref36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Burggren</surname>
<given-names>WW</given-names>
</name>
</person-group>
<article-title>Epigenetics and transgenerational transfer: A physiological perspective</article-title>
<source/>J Exp Biol
          <year>2010</year>
<volume>213</volume>
<fpage>3</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">20008356</pub-id>
</element-citation>
</ref>
<ref id="ref37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Friso</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Epigenetics: A New Bridge between Nutrition and Health</article-title>
<source/>Adv Nutr
          <year>2010</year>
<volume>1</volume>
<fpage>8</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">22043447</pub-id>
</element-citation>
</ref>
<ref id="ref38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Epigenetics in cancer</article-title>
<source/>Carcinogenesis
          <year>2010</year>
<volume>31</volume>
<fpage>27</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">19752007</pub-id>
</element-citation>
</ref>
<ref id="ref39">
<label>39</label>
<element-citation publication-type="book">
<article-title>Epigenetics and Health [Internet]</article-title>
<year>2013</year>
<date-in-citation>Last assessed on 2016 Mar 21</date-in-citation>
<publisher-loc>London</publisher-loc>
<publisher-name>The Parlimentary Office of Science and Technology</publisher-name>
<comment>Avaliable from: <uri xlink:href="http://www.parliament.uk/post" xlink:type="simple">http://www.parliament.uk/post</uri></comment>
</element-citation>
</ref>
<ref id="ref40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mellor</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Epigenetics and aging</article-title>
<source/>Biochem Soc
          <year>2010</year>
<volume>2</volume>
<fpage>14</fpage>
<lpage>17</lpage>
</element-citation>
</ref>
<ref id="ref41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berdasco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Esteller</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Genetic syndromes caused by mutations in epigenetic genes</article-title>
<source/>Hum Genet
          <year>2013</year>
<volume>132</volume>
<fpage>359</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">23370504</pub-id>
</element-citation>
</ref>
<ref id="ref42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skinner</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Manikkam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Guerrero-Bosagna</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Epigenetic transgenerational actions of environmental factors in disease etiology</article-title>
<source/>Trends Endocrinol Metab
          <year>2010</year>
<volume>21</volume>
<fpage>214</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">20074974</pub-id>
</element-citation>
</ref>
<ref id="ref43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barros</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Offenbacher</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Epigenetics: Connecting environment and genotype to phenotype and disease</article-title>
<source/>J Dent Res
          <year>2009</year>
<volume>88</volume>
<fpage>400</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">19493882</pub-id>
</element-citation>
</ref>
<ref id="ref44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ling</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Groop</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Epigenetics: A molecular link between environmental factors and type 2. diabetes</article-title>
<source/>Diabetes
          <year>2009</year>
<volume>58</volume>
<fpage>2718</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="pmid">19940235</pub-id>
</element-citation>
</ref>
<ref id="ref45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Champagne</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Curley</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Epigenetic mechanisms mediating the long-term effects of maternal care on development</article-title>
<source/>Neurosci Biobehav Rev
          <year>2009</year>
<volume>33</volume>
<fpage>593</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="pmid">18430469</pub-id>
</element-citation>
</ref>
<ref id="ref46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manikkam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tracey</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guerrero-Bosagna</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>MK</given-names>
</name>
</person-group>
<article-title>Dioxin (TCDD) induces epigenetic transgenerational inheritance of adult onset disease and sperm epimutations</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e46249</fpage>
<pub-id pub-id-type="pmid">23049995</pub-id>
</element-citation>
</ref>
<ref id="ref47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bossdorf</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Pigliucci</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Epigenetics for ecologists</article-title>
<source/>Ecol Lett
          <year>2008</year>
<volume>11</volume>
<fpage>106</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">18021243</pub-id>
</element-citation>
</ref>
<ref id="ref48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuang</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Epigenetics and microRNAs</article-title>
<source/>Pediatr Res
          <year>2007</year>
<volume>61</volume>
<issue>5 Pt 2</issue>
<fpage>24R</fpage>
<lpage>9R</lpage>
</element-citation>
</ref>
<ref id="ref49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lund</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Lohuizen</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Epigenetics and cancer</article-title>
<source/>Genes Dev
          <year>2004</year>
<volume>18</volume>
<fpage>2315</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">15466484</pub-id>
</element-citation>
</ref>
<ref id="ref50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Amasino</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Vernalization and epigenetics: How plants remember winter</article-title>
<source/>Curr Opin Plant Biol
          <year>2004</year>
<volume>7</volume>
<fpage>4</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">14732435</pub-id>
</element-citation>
</ref>
<ref id="ref51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Takai</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The role of DNA methylation in mammalian epigenetics</article-title>
<source/>Science
          <year>2001</year>
<volume>293</volume>
<fpage>1068</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">11498573</pub-id>
</element-citation>
</ref>
<ref id="ref52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newman</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Epigenetic mechanisms of character origination</article-title>
<source/>J Exp Zool
          <year>2000</year>
<volume>288</volume>
<fpage>304</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="pmid">11144279</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>